Stattic enhances the anti-proliferative effect of docetaxel via the Bax/Bcl-2/cyclin B axis in human cancer cells

Process Biochemistry(2018)

引用 15|浏览16
暂无评分
摘要
•Stattic enhances the efficacy of docetaxel by changing the cell cycle distribution of DU-145 prostate cancer cells.•Co-treatment of docetaxel and stattic has a strong synergistic effect.•Combination treatment with two agents (stattic and docetaxel) increase apoptotic cell death in comparison to single treatment.•Comparison of single treatment, combinatorial treatment with stattic and docetaxel leads to decreases the expression of key anti-apoptotic genes (Bcl-2, Bcl-xl).
更多
查看译文
关键词
Docetaxel (PubChem CID: 44408087),Stattic (PubChem CID: 2779853),Thiazolyl Blue Tetrazolium Bromide,MTT (PubChem CID: 64965),Dimethyl Sulfoxide (PubChem CID: 21584481),Trypan blue (PubChem CID: 5479131)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要